I

InFlectis BioScience

10 employees

InFlectis BioScience is a private drug discovery company aiming at targeting.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Amyotrophic Lateral Scelrosis
Multiple sclerosis
Neuromuscular diseases
Integrated Stress Response
MS
ALS
Charcot-Marie-Tooth
CMT
Pharmaceutical
Inflammatory diseases
Clinical Stage
ISR modulators
Health Care
Orphan diseases
IFB-088
Medical
Biopharma
Protein misfolding diseases

Date founded

2013

Funding rounds raised

Total raised

$6.7M

from 4 investors over 4 rounds

I

InFlectis BioScience raised $6.7M on June 3, 2016

Investors: Remiges Ventures, Inc., Crédit Mutuel Innovation and GO CAPITAL

I

InFlectis BioScience raised $2.1M on January 13, 2015

Investors: GO CAPITAL

FAQ